The article you requested is
Risperidone-Induced Ejaculatory and Urinary Dysfunction
J Clin Psychiatry 1996;57:549-550 [letter]
Copyright 1996 Physicians Postgraduate Press, Inc.
To view this item, select one of the options below.
Purchase this PDF for $30
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($125) or print + online ($161 individual).
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send an email
Letter to the Editor
Sir: Risperidone is a benzisoxazole derivative antipsychotic
agent with serotonin 5-HT2 and dopamine D2 antagonistic properties.
During premarketing evaluation of this compound, diminished
sexual desire, erectile dysfunction, and orgasmic dysfunction
were noted in at least 5% of patients.1 In addition,
product information lists dysuria and other urinary difficulties
among risperidone’s adverse events.